Dr. Dale J. Lange, MD

Dr. Lange practices at Hospital for Special Surgery in New York, New York, part of Hospital for Special Surgery.

Dr. Lange's NPI, 1528038841, was assigned on January 26, 2006. Dr. Lange graduated from New York Medical College in 1978. Dr. Lange holds New York license 150048.

Dr. Lange's primary practice is Hospital for Special Surgery, at 535 East 70th Street, New York, NY 10021 in New York County. The practice phone is (212) 606-1000.

Dr. Lange's primary practice is Hospital for Special Surgery in New York, New York, part of Hospital for Special Surgery. The medical group on file is Lange Neurology. Dmand AI also links Dr. Lange to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lange practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lange's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lange is licensed in New York.

CMS data shows 819 Medicare services from Dr. Lange across 9 procedure codes in 2024, for 68 Medicare patients. Medicare paid $60,089 for them. Every service was in an office.

CMS counts 68 Medicare patients who saw Dr. Lange in 2024. The largest group is 75 to 84, with 28 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lange's median patient age at 70, with 42% women.

In 2024, Dr. Lange wrote 248 Medicare Part D claims for 29 patients. 33% of them were for generic drugs. CMS names the drug for 165 of them, across 8 drugs with 11 or more claims each, at $2,950,524 in total drug cost. In 2023, CMS named 106 claims across 5 drugs.

Dr. Lange accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lange as offering telehealth.

Dmand AI links 22 papers to Dr. Lange, published from 2011 to 2024. 2012 was the busiest year, with 4. The most frequent topics are Amyotrophic Lateral Sclerosis, Magnetic Resonance Imaging and Motor Cortex. Dr. Lange has published most often in Amyotroph Lateral Scler Frontotemporal Degener. Dr. Lange's most frequent co-authors are Michael Benatar, MD, Andrew Damien Schweitzer, MD and Yi Wang, MD.

Dmand AI links Dr. Lange to 11 clinical trials, 4 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Amyotrophic Lateral Sclerosis, TDP-43 Proteinopathies and Motor Neuron Disease. ZevraDenmark sponsors the most, 2. Open Payments lists research payments to Dr. Lange that name 2 trials.

CMS Open Payments shows 45 general payments to Dr. Lange from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Alexion Pharmaceuticals, Inc. paid the most, $10,650. It also lists 5 research payments totaling $5,746 from 2019 to 2025, naming 2 clinical trials.

Dr. Lange graduated from New York Medical College in 1978.